Stock Trend Analysis Report
Prepared for you on Sunday, March 26, 2023.
Loncar Cancer Immunotherapy ETF (NASDAQ:CNCR)
Strong Downtrend (-100) - CNCR is in a strong downtrend that is likely to continue. With short-term, intermediate, and long-term bearish momentum, CNCR continues to fall. Traders should use caution and set stops.
Is it time to buy, sell, or avoid CNCR?
MarketClub looks at technical strength and momentum to determine if the timing is right for CNCR.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
MarketClub’s Trade Triangles for CNCR
The long-term trend has been DOWN since Dec 19th, 2022 at 13.98
The intermediate-term trend has been DOWN since Feb 13th, 2023 at 14.45
The short-term trend has been DOWN since Feb 7th, 2023 at 14.95
Smart Scan Analysis for CNCR
Based on our trend formula, CNCR is rated as a -100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
|Year High||32.32||Year High Date||2018-03-13|
|Year Low||19.1252||Year Low Date||2018-10-29|
|52wk High||19.3565||52wk High Date||2022-04-05|
|52wk Low||11.68||52wk Low Date||2023-03-23|
|Average Volume||2,884||Shares Outstanding||100|